Responses
Regular and Young Investigator Award Abstracts
Clinical Trial In Progress
740 Pattern of natural killer (NK) cell (CD16+CD56+) expansion correlates with response outcomes with nemvaleukin alfa treatment
Compose a Response to This Article
Other responses
No responses have been published for this article.
